FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Johannes Nippgen

Research Profile

Procedures

Antineoplastic Combined Chemotherapy Protocols

Chemicals & Drugs

Concepts & Ideas

Disorders

Physiology

Disease Progression

Anatomy

Wolffian Ducts

Co-author Network

Publications

TOP 3
Eric Van Cutsem; Claus-Henning Köhne; Erika Hitre; Jerzy Zaluski; Chung-Rong Chang Chien; Anatoly Makhson; Geert D'Haens; Tamás Pintér; Robert Lim; György Bodoky; Jae Kyung Roh; Gunnar Folprecht; Paul Ruff; Christopher Stroh; Sabine Tejpar; Michael Schlichting; Johannes Nippgen; Philippe Rougier
Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer.
Jean-Luc Raoul; Jean-Luc Van Laethem; Marc Peeters; Catherine Brezault; Fares Husseini; Laurent Cals; Johannes Nippgen; Anja-Helena Loos; Philippe Rougier
Cetuximab in combination with irinotecan/5-fluorouracil/folinic acid (FOLFIRI) in the initial treatment of metastatic colorectal cancer: a multicentre two-part phase I/II study.
David A Reardon; Karen L Fink; Tom Mikkelsen; Timothy F Cloughesy; Alison O'Neill; Scott Plotkin; Michael Glantz; Paula Ravin; Jeffrey J Raizer; Keith M Rich; David Schiff; William R Shapiro; Susan Burdette-Radoux; Edward J Dropcho; Sabine M Wittemer; Johannes Nippgen; Martin Picard; L Burt Nabors
Randomized phase II study of cilengitide, an integrin-targeting arginine-glycine-aspartic acid peptide, in recurrent glioblastoma multiforme.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Johannes Nippgen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Eric Van Cutsem; Claus-Henning Köhne; Erika Hitre; Jerzy Zaluski; Chung-Rong Chang Chien; Anatoly Makhson; Geert D'Haens; Tamás Pintér; Robert Lim; György Bodoky; Jae Kyung Roh; Gunnar Folprecht; Paul Ruff; Christopher Stroh; Sabine Tejpar; Michael Schlichting; Johannes Nippgen; Philippe Rougier
Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer.
The New England journal of medicine 2009;360(14):1408-17.
2009: Jean-Luc Raoul; Jean-Luc Van Laethem; Marc Peeters; Catherine Brezault; Fares Husseini; Laurent Cals; Johannes Nippgen; Anja-Helena Loos; Philippe Rougier
Cetuximab in combination with irinotecan/5-fluorouracil/folinic acid (FOLFIRI) in the initial treatment of metastatic colorectal cancer: a multicentre two-part phase I/II study.
BMC cancer 2009;9():112.
2008: David A Reardon; Karen L Fink; Tom Mikkelsen; Timothy F Cloughesy; Alison O'Neill; Scott Plotkin; Michael Glantz; Paula Ravin; Jeffrey J Raizer; Keith M Rich; David Schiff; William R Shapiro; Susan Burdette-Radoux; Edward J Dropcho; Sabine M Wittemer; Johannes Nippgen; Martin Picard; L Burt Nabors
Randomized phase II study of cilengitide, an integrin-targeting arginine-glycine-aspartic acid peptide, in recurrent glioblastoma multiforme.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(34):5610-7.
2008: Leticia Oliveira-Ferrer; Jessica Hauschild; Walter Fiedler; Carsten Bokemeyer; Johannes Nippgen; Ilhan Celik; Gunter Schuch
Cilengitide induces cellular detachment and apoptosis in endothelial and glioma cells mediated by inhibition of FAK/src/AKT pathway.
Journal of experimental & clinical cancer research : CR 2008;27():86.
2006: Oliver W Hakenberg; Johannes Nippgen; Michael Froehner; Stefan Zastrow; Manfred P Wirth
Cisplatin, methotrexate and bleomycin for treating advanced penile carcinoma.
BJU international 2006;98(6):1225-7.
2006: Helmut Friess; Jan M Langrehr; Helmut Oettle; Jochen Raedle; Marco Niedergethmann; Christian Dittrich; Dieter K Hossfeld; Herbert Stöger; Bart Neyns; Peter Herzog; Pascal Piedbois; Frank Dobrowolski; Werner Scheithauer; Robert Hawkins; Frieder Katz; Peter Balcke; Jan Vermorken; Simon van Belle; Neville Davidson; Albert Abad Esteve; Daniel Castellano; Jörg Kleeff; Adrien A Tempia-Caliera; Andreas Kovar; Johannes Nippgen
A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer.
BMC cancer 2006;6():285.
2005: Navid Berdjis; Axel Meye; Johannes Nippgen; Dag Dittert; Oliver W Hakenberg; Gustavo B Baretton; Manfred P Wirth
Expression of Ki-67 in squamous cell carcinoma of the penis.
BJU international 2005;96(1):146-8.
2004: Stefan Zastrow; Johannes Nippgen; Andreas Manseck; Manfred P Wirth
[Syndrome of persisting mullerian duct with first manifestation in an adult].
Aktuelle Urologie 2004;35(6):502-4.
2003: Manfred P Wirth; Johannes Nippgen
[Chemotherapy of hormone refractory prostate carcinoma].
Der Urologe. Ausg. A 2003;42(11):1453-60.
2001: Johannes Nippgen; Oliver W Hakenberg; Andreas Manseck; Manfred P Wirth
Spontaneous late rupture of orthotopic detubularized ileal neobladders: report of five cases.
Urology 2001;58(1):43-6.